Identify the Cause of Your Ataxia Symptoms

One test, clear answers.

Genomic Unity® provides the most comprehensive genetic testing available.

Learn about testing today

What is ataxia?

Ataxia is a neurological disorder that affects movement, causing unsteady walking. Symptoms worsen over time, often leading to severe mobility challenges. Ataxia can also cause:

  • Dizziness
  • Tremors
  • Difficulty speaking or swallowing

While symptoms can begin in childhood, they often first appear in adulthood.

Why genetic testing is critical

Ataxia can be caused by DNA changes in >50 different genes – including many with complex changes known as repeat expansions1.

Genetic testing is essential to confirm a diagnosis and guide treatment. Early genetic testing may:

  • Inform prognosis
  • Identify targeted treatments or clinical trials
  • Guide family planning decisions

Genomic Unity® provides the most comprehensive testing

When it comes to genetic testing, technology matters.

Traditional testing often involves sequential tests that may miss crucial information. Genomic Unity® uses whole genome sequencing to detect DNA changes ranging in size from single base changes to large structural changes – including repeat expansions in >20 movement disorder genes – with a single test.

Our advanced technology ensures the most accurate and complete results available.

 

Why choose Genomic Unity®?

  • One test replaces multiple sequential tests
  • Covers >20 movement disorder repeat expansion genes*
  • Get your results in just 4-8 weeks
  • Simple insurance and self-pay options

*Including BEAN1, FGF14, FXN, RFC1, and ZFH3.

Ask your doctor about Genomic Unity® testing for ataxia

Ask your doctor about Genomic Unity® testing

Talking with your healthcare provider is the first step. Start a conversation using these questions:

  • What type of genetic test is best for my symptoms?
  • What genetic conditions can the test detect or miss?
  • How accurate are the results?

FAQs

    • Genomic Unity® is recommended if your healthcare provider suspects ataxia or another movement disorder.

    • Genomic Unity® detects many types of ataxia including:

      • Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS)
      • Dentatorubral-pallidoluysian atrophy (DRPLA)
      • Friedreich’s ataxia
      • Global developmental delay, progressive ataxia, and elevated glutamine (GDPAG)
      • Spinocerebellar ataxias 1, 2, 3, 4, 6, 7, 8, 10, 12, 17, 27B, 31, 36

      It also detects related movement disorders including:

      • Amyotrophic lateral sclerosis (ALS)
      • Huntington’s disease
      • Parkinson’s disease

    • Genomic Unity® detects repeat expansions in the following ataxia genes: ATN1, ATXN1, ATXN2, ATXN3, ATXN7, ATXN8OS, ATXN10, BEAN1*, CACNA1A, FGF14, FMR1, FXN, GLS, NOP56, PPP2R2B, RFC1, TBP, and ZFHX3.

      It also detects repeat expansions in the following related movement disorder genes: HTT, JPH3, and NOTCH2NLC.

      View all repeat expansions detected by Variantyx testing.

      *BEAN1 repeat expansions are only detected when Genomic Unity® 2.0 is ordered.

    • A test report is sent to your doctor within 4-8 weeks of receiving your sample.

    • Yes! Genomic Unity® is covered by most insurances. For cases where insurance coverage is not available, we offer self-pay options.

    • Genomic Unity® testing must be ordered by a healthcare provider.

      If your healthcare provider needs assistance with obtaining test order forms, sample collection kits, etc, please contact us – we’re happy to help.

    • Visit the National Ataxia Foundation for more resources about diagnosis, treatment, and support.

Ready to learn more?

Connect with a Clinical Specialist to discuss Genomic Unity® testing. We’re here to help you understand your options.

Let’s talk